Jing-Lin X, Sharma D, Bing-Hui Y, Bo-Heng Z, Zeng-Chen M, Zhi-Quan W, Jia F, Xin Z D, Lun-Xiu Q, Zhao-You X
Liver Cancer Institute, Zhongshan Hospital, Fudan University, Shanghai 200032, P.R., China.
JNMA J Nepal Med Assoc. 2008 Jul-Sep;47(171):132-5.
The peak age of onset of hepatocellular carcinoma (HCC) is continually increasing worldwide. This study aims to evaluate whether there exists any significant difference in the clinicopathological features between younger- and elderly-HCC.1082 Consecutive patients with HCC who underwent liver resection at Liver Cancer Institute, Zhongshan Hospital, Fudan University from 1995 to 1998 were studied. The patients were divided into elderly-HCC (>or=65 years of age) and younger-HCC (< 65 years of age). Important clinicopathological features of the patients and postoperative survival rates were compared between these two groups. Among 1082 patients studied, 108 were elderly-HCC and 974 were younger-HCC. The resection rate of the elderly-HCC was significantly higher than that of the younger-HCC. The 1, 3 and 5-year survival rates of the elderly-HCC were not significantly different from those of the younger-HCC. Compared with the younger-HCC, the elderly-HCC had (1) less HBsAg-positive rate; (2) more frequent anti-HCV positivity ; (3) lower proportion with AFP value >or=400 microg/dl; (4) a relatively small tumor diameter; (5) higher proportion of stage I-II patients; (6) a relatively low metastasis rate. However, there were no statistically significant differences in other clinicopathological features (including gender, symptoms, tumor number, tumor venous invasion, tumor differentiation, capsular formation, type of cirrhosis) between the two groups. There is a certain extent difference in clinicopathological features between elderly and younger-HCC patients, but the postoperative survival rate is comparable between the two groups.
在全球范围内,肝细胞癌(HCC)的发病高峰年龄持续上升。本研究旨在评估老年HCC与年轻HCC在临床病理特征方面是否存在显著差异。对1995年至1998年在复旦大学附属中山医院肝癌研究所接受肝切除手术的1082例连续HCC患者进行了研究。患者被分为老年HCC(年龄≥65岁)和年轻HCC(年龄<65岁)。比较了两组患者的重要临床病理特征及术后生存率。在1082例研究患者中,108例为老年HCC,974例为年轻HCC。老年HCC的切除率显著高于年轻HCC。老年HCC的1年、3年和5年生存率与年轻HCC相比无显著差异。与年轻HCC相比,老年HCC具有以下特点:(1)HBsAg阳性率较低;(2)抗-HCV阳性率较高;(3)AFP值≥400μg/dl的比例较低;(4)肿瘤直径相对较小;(5)I-II期患者比例较高;(6)转移率相对较低。然而,两组在其他临床病理特征(包括性别、症状、肿瘤数量、肿瘤静脉侵犯、肿瘤分化、包膜形成、肝硬化类型)方面无统计学显著差异。老年和年轻HCC患者在临床病理特征上存在一定程度差异,但两组术后生存率相当。